Sign inJoin waitlistJoin the waitlist

Christine M. Hay

Professor - Department of Medicine, Infectious Diseases · URochester Medicine

Credentials: · · ·

History

URochester Medicine
Present

Massachusetts General Hospital
1995–1998
Massachusetts General Hospital
1993–1995
Massachusetts General Hospital
1992–1993
Washington University School of Medicine
1992

Research

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial
JAMA · 2007 · 148 citations
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles
The Journal of Infectious Diseases · 2011 · 139 citations
Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults
Vaccine · 2010 · 122 citations

JT
John Treanor
4 papers
Spyros Kalams
4 papers
BW
Bruce Walker
3 papers
Juliana McElrath
3 papers
Magdalena Sobieszczyk
3 papers
ME
Marnie Elizaga
3 papers
Nesli Basgoz
3 papers
Rebecca Brady
3 papers
Susan Buchbinder
3 papers
Emmanuel Walter
2 papers
ER
Eric Rosenberg
2 papers
GW
Gregory Wilson
2 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $228.7K · University of Rochester
2005–2006
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $2K · Columbia University Health Sciences
2003–2004
Immune Control of hiv1 Disease Progression
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $303.3K · Columbia University Health Sciences
1998–2001
Hiv Ctl in Progressive and Non-Progressive Infection
National Institute of Allergy and Infectious Diseases · F32
Contact PI · $33.5K · Massachusetts General Hospital
1997

Clinical trials

Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2012–2016
Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2012–2016
Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2007–2008
Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2006–2008